Hughes Owen

Hughes Owen is listed in filings as Director at AnaptysBio, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including purchase activity and sale activity. Recent filings connect the profile to AnaptysBio, Inc. (ANAB), XOMA Royalty Corp. (XOMA), and C4 Therapeutics, Inc. (CCCC). The current snapshot covers public activity from Jun 21, 2024 to May 13, 2026. Reported amounts are shown as $2.5M to $650.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.